4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001140361-15-045654
President & CEO sold 63,209 shares at an average $39.06 ($2,468,633)
- President & CEO acquired 63,209 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Abdun-Nabi Daniel · President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-12-23 | Exercise or conversion : show line 1 in the form | +40,354 | $18.90 | $762,691 | 225,722 | D |
| 2015-12-23 | Sale : show line 2 in the form | −40,354 | $38.99 | $1,573,402 | 185,368 | D |
| 2015-12-24 | Exercise or conversion : show line 3 in the form | +22,855 | $18.90 | $431,960 | 208,223 | D |
| 2015-12-24 | Sale : show line 4 in the form | −22,855 | $39.17 | $895,230 | 185,368 | D |
| Open-market sales · 63,209 sh · avg $39.06 · $2,468,633 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-12-23 | Exercise or conversion : show line 5 in the form Stock Option | −40,354 | $18.90 | 2019-03-09 | 40,354 | 22,855 | D |
| 2015-12-24 | Exercise or conversion : show line 6 in the form Stock Option | −22,855 | $18.90 | 2019-03-09 | 22,855 | 0 | D |
Loading xslF345X03/doc1.xml…